Madrigal Pharmaceuticals, Inc. (LON:0JXI)
London
· Delayed Price · Currency is GBP · Price in USD 324.45
+8.45 (2.67%)
At close: Mar 12, 2025
Madrigal Pharmaceuticals Revenue
In the year 2024, Madrigal Pharmaceuticals had annual revenue of $180.13M USD. Madrigal Pharmaceuticals had revenue of $103.32M in the quarter ending December 31, 2024.
Revenue
$180.13M
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
$341.16K
Employees
528
Market Cap
5.51B GBP
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| Shell | 227.10B |
| HSBC Holdings | 48.93B |
| Unilever | 50.25B |
| Rio Tinto Group | 42.86B |
| British American Tobacco p.l.c. | 25.87B |
| RELX PLC | 9.43B |
| BP p.l.c. | 149.68B |